A randomised placebo controlled crossover trial to evaluate the effects of a D-xylose preload, with or without sitagliptin, on incretin hormone secretion, gastric emptying, and postprandial glycaemia in patients with type 2 diabetes mellitus.
Phase of Trial: Phase IV
Latest Information Update: 05 Oct 2018
At a glance
- Drugs Sitagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 05 Oct 2018 Results presented at the 54th Annual Meeting of the European Association for the Study of Diabetes
- 01 Nov 2012 New source identified and integrated (Australian New Zealand Clinical Trials Registry).
- 20 Oct 2012 New trial record